BCRX
ANALYST COVERAGE28 analysts
BUY
+66.9%upside to target
L $8.00
Med $15.00consensus
H $25.00
Buy
2589%
Hold
311%
25 Buy (89%)3 Hold (11%)0 Sell (0%)
Full report →
PRICE
Prev Close
9.02
Open
9.03
Day Range8.76 – 9.06
8.76
9.06
52W Range6.00 – 11.31
6.00
11.31
56% of range
VOLUME & SIZE
Avg Volume
5.5M
FUNDAMENTALS
P/E Ratio
-5.1x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.27
Market-like
TECHNICAL
RSI (14)
62
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 102 days
Aug 28
Key MetricsTTM
Market Cap$1.89B
Revenue TTM$885.72M
Net Income TTM-$457.98M
Free Cash Flow$293.58M
Gross Margin18.9%
Operating Margin-43.1%
Net Margin-51.7%
Return on Equity123.6%
Return on Assets-98.5%
Debt / Equity-1.55
Current Ratio1.91
EPS TTM$-1.89

BCRX News

About

biocryst pharmaceuticals, a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. founded in 1986, biocryst has more than 50 employees and is experiencing continued growth. the company’s headquarters are located in research triangle park, north carolina and its discovery center of excellence is in birmingham, alabama. with expertise in drug discovery, clinical development, regulatory affairs and product commercialization, we continue to advance our clinical programs and to generate new compounds from our own discovery engine. we are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. the commitment of biocryst remains unchanged. we continue to be passionate about developing and marketing novel therapeutics for patients with rare and serious diseases.

Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Jon Stonehouse
Babar GhiasChief Financial Officer & Head of Corporate Development
Charles K. GayerCEO, President & Director
John RueschChief Technical Operations Officer
Philip GeorgeChief Strategy Officer
Alane BarnesSenior Vice President, Chief Legal Officer & Corporate Secretary
Nick WilderManager of Investor Relations
William Sheridan MBBSChief Development Officer
Yarlagadda S. BabuChief Discovery Officer
Jinky Ang RosselliChief Data Innovation Officer
Stephanie AngeliniChief People Officer & Chief Communications Officer